Login

Here's a preview of our upcoming interview with Ko Yun Hung, Managing Director of ACE Market-bound SNS Network Technology. 00:10:00

Share On Facebook Share On Twitter

SNS Network Technology Berhad's CEO is Yun Hung Ko

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
CEO Rosario Pingaro Discusses the Future-Proof Vision of Convergenze: A Leading Multiutility | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Understanding the U.S. Tax System and Capital Gains
00:10:00
SEPA President and CEO Julia Hamm hosts a CEO interview series featuring PNM Resources, Inc., discussing its role as an investor-owned utility in the energy sector.
00:10:00
Invisio Communations Presents at ABGSC Investor Days | Lars Højgård Hansen - CEO of INVISIO AB
00:10:00
AeroVironment CEO Discusses Quarterly Earnings and Defense Tech Innovation | WAHID NAWABI - CHAIRMAN, PRESIDENT & CHIEF EXECUTIVE OFFICER of AeroVironment
00:10:00
Kingston Resources: Revitalizing Gold Production at the Historic Misima Project in Papua New Guinea
00:10:00
Navigating Challenges and Opportunities with Critical Raw Materials
00:10:00
Charles Murray on America's Civic Culture and Family Changes|Charles Murray
00:10:00
Transitioning from Coal to Biomass: Drax's Impact on the UK's Renewable Energy Landscape and Carbon Capture Initiatives| Will Gardiner, CEO, Drax Group PLC.
00:10:00
Relationship-first fund investing in early stage startups|Joachim Laqueur,General Partner,Acrobator Ventures
00:10:00
Sitowise's Year 2023 with CEO Heikki Haasmaa | Heikki Haasma, CEO, Sitowise Group Oyj.
00:10:00
The Living Financial Plan: Adapting to Your Needs | Mike Wern, Principal, Legacy Financial Strategies, LLC.

© 2026 Nehu